Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-17.04%EBITDA Margin
VS
Market
Sector
Industry
History
$ 2.2Close
$ 1.22 - $ 3.46 52-Week Range
Ticker Information
Ticker
SBFMCompany Name
SUNSHINE BIOPHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQSUNSHINE BIOPHARMA INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SBFM - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -6.19M | -17.04% | $ 36.34M |
| 3/31/2025 | $ -5.07M | -14% | $ 36.23M |
| 12/31/2024 | $ -5.14M | -14.73% | $ 34.87M |
| 9/30/2024 | $ -3.83M | -11.63% | $ 32.96M |
| 6/30/2024 | $ -3.45M | -11.31% | $ 30.48M |
| 3/31/2024 | $ -3.41M | -12.77% | $ 26.74M |
| 12/31/2023 | $ -3.82M | -15.87% | $ 24.09M |
| 9/30/2023 | $ -26.1M | -128.24% | $ 20.35M |
| 6/30/2023 | $ -27.02M | -186.01% | $ 14.53M |
| 3/31/2023 | $ -26.81M | -294.03% | $ 9.12M |
Key Performance Insights, Last 5 Years
- SUNSHINE BIOPHARMA INC's latest trailing twelve months (TTM) EBITDA % stands at -3643.64%.
- Over the past 5 years, SUNSHINE BIOPHARMA INC's average EBITDA % has been -894.16%.
- The median EBITDA % for SUNSHINE BIOPHARMA INC during this period was -157.12%
- SUNSHINE BIOPHARMA INC reached its highest EBITDA % over the past 5 years at -11.31%.
- The lowest EBITDA % recorded by SUNSHINE BIOPHARMA INC in the same timeframe -5294.88%
SUNSHINE BIOPHARMA INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for SUNSHINE BIOPHARMA INC is calculated as follows: EBITDA [ $ -2.6M ] / Revenues [ $ 71.41K ]
(=) EBITDA % [ -3643.64% ] SBFM - EBITDA Margin, Last 5 years
-5294.88%
Minimum
Dec 31, 2021
-11.31%
Maximum
Jun 30, 2024
-894.16%
Average
-157.12%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.89%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.89% |